Tuesday's Health Winners & Losers

10/23/07 - 04:15 PM EDT

Elizabeth Trotta

Also rising, Bentley Pharmaceuticals(BNT Quote - Cramer on BNT - Stock Picks) announced that its board of directors unanimously approved a plan to spin off its drug-delivery business into a separate company and explore strategic alternatives for its generic-pharmaceuticals business. Shares rose $1.11, or 8.8%, to $13.74.

Then, Genomic Health(GHDX Quote - Cramer on GHDX - Stock Picks) reported that its Oncotype D.X. breast cancer assay, used to predict the likelihood of disease recurrence and likelihood of chemotherapy benefit for node-negative, estrogen receptor-positive breast cancer patients, has been included in updated guidelines on the use of breast cancer tumor markers by the American Society of Clinical Oncology. The guidelines were published Tuesday in the Journal of Clinical Oncology and will appear in the journal's Nov. 20 print edition. Shares gained $3.39, or 16.5%, to $24.

Elsewhere, earnings and clinical data gave other health stocks a kick. ZymoGenetics(ZGEN Quote - Cramer on ZGEN - Stock Picks) announced positive interim data from a phase I trial that combined its IL-21 and kidney cancer drug Nexavar, owned by Bayer(BAY Quote - Cramer on BAY - Stock Picks) and Onyx Pharmaceuticals(ONXX Quote - Cramer on ONXX - Stock Picks). ZymoGenetics said the combined therapy was well-tolerated, with a toxicity profile similar to known toxicities of each agent alone, and that it has also shown promising anti-tumor activity.

Shares added 40 cents, or 3.2%, to $13. The stock is a component of the Nasdaq biotechnology index, which was up 13.72, or 1.6%, to 886.316 Tuesday.

Medical-device company Arthrocare(ARTC Quote - Cramer on ARTC - Stock Picks) gained $5.29, or 9.3%, to $61.97 after announcing a 28% year-over-year rise in third-quarter profit and a 21% rise in revenue post-close Monday. It also increased its full-year guidance for 2007. Banc of America Securities analyst Steven Lichtman raised his price target for Arthrocare to $65 from $52.

1 2
Next Page »
Back to Yahoo

Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Sign up for our FREE newsletters now. See All

  • Cramer's Daily Booyah!
  • Before the Bell

Premium Stock Ideas
Access Action Alerts Plus to find out Cramer’s latest picks now!